Tag: Health Costs
Potentially Preventable Spending Concentrated in Frail Elderly
Variation in preventable spending across Medicare subpopulations; 43.9 percent of total in frail elderly
Low-Cost Services a Major Player in Unnecessary Health Spending
Costs associated with low-cost, low-value health services nearly twice as high as high-cost services
Stronger Nocebo Effect When Inert Rx Labeled As Expensive
Neural interactions between cortex, brainstem, and spinal cord mediate this effect
Participation in SNAP Can Cut Health Care Expenditures
In fully adjusted models, SNAP linked to lower annual health care expenditure for low-income adults
Insurer Market Power Lowers Providers’ Prices
Evidence seen for specialists in markets with high provider, insurer concentration
Median Cost of Cancer Drug Development $648.0 Million
Total revenue from sales of 10 drugs was $67.0 billion, with total R&D spending of $7.2 billion
More Evidence Evolocumab Exceeds Cost-Effectiveness
Findings for addition of evolocumab to standard tx in atherosclerotic cardiovascular disease
Cost-Effectiveness of PCSK9 Inhibitors Called Into Question
Researchers say price would have to be between $4,000 and $5,000 per year to be cost-effective
Families Shoulder Majority of Costs Related to Dementia Care
Reducing functional decline or behavioral and psychological symptoms leads to lower lifetime costs
Limited Economic Evidence for Vitiligo Treatments
Research reveals no evidence to support or refute value for money afforded by vitiligo treatments
